During the early stages of his career, Dr. Diallo gained valuable expertise in regulatory affairs, quality control, and more through Cardinal Health, Pfizer Inc., and Shire Pharmaceuticals.
JEFFERSON, MA, August 06, 2024 /24-7PressRelease/ -- Mamadou Tahirou Diallo, PharmD has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Diallo, a seasoned healthcare director with over two decades of biopharmaceutical and drug development expertise, played a pivotal role in the COVID-19 vaccine rollout. His leadership as the director of global regulatory affairs for Cardinal Health is evident in his team's focus on biological medicines development. Likewise, his work was instrumental in the Food and Drug Administration approval process for the COVID-19 vaccine, and many other biological medicines for the treatment of unmet medical needs, demonstrating his leadership and expertise.
During the early stages of his career, Dr. Diallo gained valuable expertise in regulatory affairs, quality control, and more through Cardinal Health, Pfizer Inc., and Shire Pharmaceuticals. Before establishing himself professionally, he received a PharmD in pharmaceutical sciences from Universite Gamal Abdel Nasser de Conakry. Subsequently, he expanded his professional knowledge by completing a biotechnology and business management certificate and a Master of Science in regulatory affairs for drugs, biologics, and medical devices from Northeastern University. Additionally, Dr. Diallo received a certificate in regulatory affairs from Duke University's School of Medicine.
Driven to remain abreast of changes in the field, Dr. Diallo aligns himself with Pharmalucent's executive board and the Regulatory Affairs Professionals Organization. He has contributed to the less fortunate through local and international charitable organizations in conjunction with his professional and educational endeavors.
Given his dedication to excellence at Cardinal Health, Dr. Diallo has received various internal awards. While his career has been filled with highlights, he takes the most pride in being part of the team that brought the COVID-19 vaccine to market. Though hard work and dedication have brought him far in his career, he credits his success to his father, who encouraged him to pursue his dreams. Within the coming years, Dr. Diallo intends to positively impact people internationally, introduce new medicines, such as cellular and gene therapies, to the market.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.
# # #